Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau
Published . Updated .
Recommended dose of hepatitis B vaccine will be withheld from thousands of newborns by Danish researchers A controversial research trial that will withhold hepatitis B vaccines from some African newborns was given approval to move forward this week. It is a central part of the vaccine vision for Robert F Kennedy Jr, the secretary of the US Department of Health and Human Services (HHS) and a longtime vaccine opponent. This article was amended on 13 October 2026. A previous version said CIDRAP first reported news that the research trial was approved by the Denmark ethics committee. Rolling Stone had actually reported the news first. Continue reading...
Directly affected
- No company is named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
A fund of health-care companies
- XBI SPDR S&P Biotech
A fund of biotechnology companies
- UNH UnitedHealth
A large health insurer
- JNJ Johnson & Johnson
A large health-care company
- LLY Eli Lilly
A large drug maker
- PFE Pfizer
A large drug maker
- PPA INVESCO AEROSPACE & DEFENSE ETF
GA selected PPA as a RELATED security because its canonical security name directly matches this event's themes: defense. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- WAR U.S. GLOBAL TECHNOLOGY AND AEROSPACE & DEFENSE ETF
GA selected WAR as a RELATED security because its canonical security name directly matches this event's themes: defense. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Recommended dose of hepatitis B vaccine will be withheld from thousands of newborns by Danish researchers A controversial research trial that will withhold hepatitis B vaccines from some African newborns was given approval to move forward…
Source: The Guardian
Invesco Aerospace & Defense Etf (PPA) since this story, compared with the market
Since the first closing price after “Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau,” Invesco Aerospace & Defense Etf (PPA) is +1.01%. The S&P 500 fund (SPY) is -1.47% over the same days, a +2.48% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -0.63% | final price |
| GLD | the next day | -0.76% | final price |
| GLD | two days later | -2.24% | final price |
| GLD | three days later | -0.50% | final price |
| GLD | three days earlier | -2.27% | final price |
| GLD | five days earlier | -1.32% | final price |
| JNJ | that day | +0.99% | final price |
| JNJ | the next day | -4.94% | final price |
| JNJ | two days later | -2.90% | final price |
| JNJ | three days later | -3.13% | final price |
| JNJ | three days earlier | -1.15% | final price |
| JNJ | five days earlier | -3.33% | final price |
| LLY | that day | +0.37% | final price |
| LLY | the next day | -0.94% | final price |
| LLY | two days later | +2.78% | final price |
| LLY | three days later | +6.24% | final price |
| LLY | three days earlier | +0.86% | final price |
| LLY | five days earlier | -2.93% | final price |
| PFE | that day | +0.53% | final price |
| PFE | the next day | +0.39% | final price |
| PFE | two days later | +3.40% | final price |
| PFE | three days later | +4.10% | final price |
| PFE | three days earlier | -1.01% | final price |
| PFE | five days earlier | -3.04% | final price |
| Invesco Aerospace & Defense Etf (PPA) | that day | -0.35% | final price |
| Invesco Aerospace & Defense Etf (PPA) | the next day | -1.23% | final price |
| Invesco Aerospace & Defense Etf (PPA) | two days later | -1.25% | final price |
| Invesco Aerospace & Defense Etf (PPA) | three days later | +0.16% | final price |
| Invesco Aerospace & Defense Etf (PPA) | three days earlier | -1.45% | final price |
| Invesco Aerospace & Defense Etf (PPA) | five days earlier | +0.49% | final price |
Who gains and who loses around Invesco Aerospace & Defense Etf (PPA)
Companies carried with this story
- PPA Invesco Aerospace & Defense Etf
In “Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau,” Invesco Aerospace & Defense Etf (PPA) is linked, with no stored direction, medium confidence. Reason on file: GA selected PPA as a RELATED security because its canonical security name directly matches this event's themes: defense. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- WAR U.S. Global Technology And Aerospace & Defense Etf
For “Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau,” U.S. Global Technology And Aerospace & Defense Etf (WAR) is linked, with no stored direction, medium confidence. Reason on file: GA selected WAR as a RELATED security because its canonical security name directly matches this event's themes: defense. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Invesco Aerospace & Defense Etf (PPA)
On 11 Oct 2026, “Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau” is the story that connects Invesco Aerospace & Defense Etf (PPA) to this story.
For Invesco Aerospace & Defense Etf (PPA), the reason on file says GA selected PPA as a RELATED security because its canonical security name directly matches this event's themes: defense. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
A second company, U.S. Global Technology And Aerospace & Defense Etf (WAR), is listed for a different reason: GA selected WAR as a RELATED security because its canonical security name directly matches this event's themes: defense. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates and price levels for Invesco Aerospace & Defense Etf (PPA)
Dates written in “Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau”: opponent. This article was amended on (13 October 2026).
PPA traded between 151.56 and 162.12 across 20 sessions. The latest close on file is 156.07. WAR traded between 27.98 and 32.67 across 18 sessions. The latest close on file is 28.45.
How strong the case is around Invesco Aerospace & Defense Etf (PPA)
21 out of 100
“Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau” scores 21 out of 100. The score uses 1 sources, and 2 linked companies.